S 3048 United States Senate · 119th Congress

TREATS Act

The TREATS Act amends the Controlled Substances Act to allow telehealth evaluations as an alternative to in-person medical evaluations for prescribing certain controlled substances. Specifically, it permits one telehealth evaluation (conducted via real-time audio/video systems meeting Social Security Act standards) instead of an in-person visit when prescribing FDA-approved medications for substance use disorder treatment (schedules III-V). This directly affects healthcare providers who prescribe these medications, expanding their ability to use telehealth for initial patient assessments. The change maintains the requirement for at least one evaluation (either in-person or telehealth) while updating the process to include telehealth options for this specific treatment context.
Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2025
Committee Review
Floor Vote
President
Introduced Oct 23, 2025 Last action Oct 23, 2025